Capital Research Global Investors Purchases 687,906 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Capital Research Global Investors grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 25.5% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 3,381,302 shares of the medical equipment provider’s stock after buying an additional 687,906 shares during the period. Capital Research Global Investors’ holdings in Intuitive Surgical were worth $1,764,904,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of ISRG. Howard Capital Management Group LLC lifted its position in shares of Intuitive Surgical by 4.5% during the third quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock worth $1,044,000 after purchasing an additional 92 shares during the last quarter. Principal Financial Group Inc. lifted its holdings in Intuitive Surgical by 1.5% during the 3rd quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider’s stock valued at $295,938,000 after buying an additional 9,194 shares in the last quarter. M&T Bank Corp boosted its position in Intuitive Surgical by 0.3% in the 3rd quarter. M&T Bank Corp now owns 68,581 shares of the medical equipment provider’s stock valued at $33,691,000 after buying an additional 226 shares during the period. World Investment Advisors LLC bought a new position in Intuitive Surgical in the 3rd quarter worth about $228,000. Finally, Arvest Bank Trust Division purchased a new position in shares of Intuitive Surgical during the third quarter worth approximately $260,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts recently issued reports on ISRG shares. Robert W. Baird lowered their price target on Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating for the company in a report on Tuesday, March 18th. Evercore ISI increased their price target on Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. UBS Group upped their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research note on Monday, January 27th. BTIG Research set a $560.00 target price on shares of Intuitive Surgical and gave the company a “buy” rating in a research report on Monday. Finally, Citigroup upped their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $611.81.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of the firm’s stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the sale, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Robert Desantis sold 11,545 shares of the firm’s stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the sale, the executive vice president now owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. The trade was a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 33,754 shares of company stock valued at $17,691,621. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $482.74 on Friday. The business has a fifty day moving average price of $522.23 and a 200 day moving average price of $532.02. The company has a market cap of $171.94 billion, a P/E ratio of 75.31, a P/E/G ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.